Profile data is unavailable for this security.
About the company
Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
- Revenue in JPY (TTM)100.09bn
- Net income in JPY3.01bn
- Incorporated1945
- Employees1.53k
- LocationMochida Pharmaceutical Co Ltd1-7, YotsuyaSHINJUKU-KU 160-8515JapanJPN
- Phone+81 333587211
- Fax+81 333587887
- Websitehttps://www.mochida.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Katakura Industries Co., Ltd. | 39.97bn | 3.05bn | 67.51bn | 1.02k | 20.87 | 0.8469 | 11.46 | 1.69 | 91.86 | 91.86 | 1,206.19 | 2,263.56 | 0.2879 | 2.26 | 4.70 | -- | 2.33 | 2.35 | 3.05 | 3.34 | 38.45 | 37.75 | 8.09 | 8.32 | 2.57 | -- | 0.1105 | 17.44 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
ASKA Pharmaceutical Holdings Co Ltd | 62.03bn | 6.51bn | 67.54bn | 747.00 | 9.61 | 1.04 | 7.17 | 1.09 | 230.05 | 230.05 | 2,191.75 | 2,131.76 | 0.6682 | 1.72 | 3.40 | 83,033,460.00 | 7.02 | 3.37 | 9.09 | 4.25 | 48.12 | 45.39 | 10.50 | 5.02 | 1.96 | -- | 0.1433 | 15.79 | 6.81 | 4.32 | -1.21 | 12.16 | -13.15 | 2.71 |
Eiken Chemical Co Ltd | 39.90bn | 2.95bn | 78.68bn | 754.00 | 24.93 | 1.45 | 15.02 | 1.97 | 78.83 | 78.83 | 1,067.99 | 1,355.09 | 0.6013 | 2.74 | 3.07 | 52,923,080.00 | 4.44 | 8.83 | 5.45 | 11.34 | 42.67 | 46.39 | 7.38 | 12.16 | 2.95 | -- | 0.0563 | 31.24 | 0.6396 | 4.34 | -7.75 | 17.07 | 0.6216 | 15.33 |
ispace Inc | 1.99bn | -2.52bn | 79.15bn | 216.00 | -- | 19.08 | -- | 39.74 | -33.88 | -33.88 | 24.76 | 44.55 | 0.1476 | -- | 24.87 | 9,219,852.00 | -18.66 | -- | -32.11 | -- | 46.91 | -- | -126.42 | -- | 1.72 | -16.86 | 0.7317 | -- | 46.74 | -- | -180.75 | -- | -- | -- |
JCR Pharmaceuticals Co Ltd | 41.37bn | 5.36bn | 111.01bn | 879.00 | 20.01 | 1.92 | 13.55 | 2.68 | 42.78 | 42.78 | 330.47 | 445.94 | 0.4253 | 0.5492 | 3.03 | 47,059,160.00 | 5.53 | 9.63 | 8.38 | 14.67 | 74.83 | 74.34 | 12.99 | 19.32 | 1.15 | 19.24 | 0.294 | 27.35 | -32.77 | 10.77 | -74.00 | 4.20 | 53.67 | 25.21 |
Zeria Pharmaceutical Co Ltd | 74.57bn | 8.64bn | 112.40bn | 1.73k | 10.80 | 1.19 | 7.22 | 1.51 | 195.97 | 195.97 | 1,691.65 | 1,780.16 | 0.514 | 1.44 | 3.37 | 43,130,530.00 | 5.96 | 3.37 | 9.31 | 5.40 | 73.90 | 71.45 | 11.60 | 6.52 | 0.8269 | -- | 0.3915 | 41.33 | 14.87 | 1.15 | 56.41 | 8.30 | 5.40 | 3.30 |
Takara Bio Inc | 47.67bn | 1.57bn | 117.28bn | 1.79k | 74.66 | 1.04 | 17.89 | 2.46 | 13.05 | 13.05 | 395.88 | 932.12 | 0.3795 | 1.47 | 2.58 | 26,586,730.00 | 1.27 | 11.78 | 1.38 | 13.36 | 55.32 | 63.90 | 3.34 | 20.22 | 5.81 | -- | 0.00 | 24.13 | 15.43 | 19.32 | -19.33 | 46.97 | 29.87 | 56.32 |
Kyorin Pharmaceutical Co Ltd | 119.83bn | 4.26bn | 117.39bn | 2.14k | 24.48 | 0.8247 | 13.86 | 0.9797 | 74.23 | 74.23 | 2,089.34 | 2,203.28 | 0.678 | 1.34 | 2.73 | 56,047,710.00 | 2.41 | 3.20 | 3.12 | 3.93 | 42.92 | 48.72 | 3.56 | 5.10 | 1.40 | -- | 0.141 | 70.57 | 7.33 | 0.471 | 20.12 | -6.40 | 19.42 | -2.16 |
Torii Pharmaceutical Co Ltd | 54.64bn | 4.12bn | 118.51bn | 583.00 | 28.08 | 0.9627 | 25.88 | 2.17 | 146.56 | 146.56 | 1,944.21 | 4,274.44 | 0.4091 | 3.03 | 2.13 | 93,718,700.00 | 3.08 | 6.52 | 3.41 | 7.35 | 45.37 | 49.55 | 7.54 | 17.98 | 6.19 | -- | 0.002 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
Mochida Pharmaceutical Co Ltd | 100.09bn | 3.01bn | 119.72bn | 1.53k | 37.88 | 0.8925 | 20.76 | 1.20 | 84.34 | 84.34 | 2,768.28 | 3,579.89 | 0.6294 | 1.86 | 2.91 | 65,457,820.00 | 1.89 | 4.86 | 2.26 | 5.94 | 51.24 | 52.20 | 3.01 | 7.36 | 3.24 | -- | 0.00 | 41.96 | -6.28 | -0.6644 | -37.09 | -5.92 | 14.62 | -1.21 |
Sosei Group Corp | 12.77bn | -7.19bn | 144.99bn | 350.00 | -- | 2.17 | -- | 11.36 | -87.73 | -87.73 | 154.90 | 746.93 | 0.0995 | -- | 3.39 | 36,474,280.00 | -5.61 | -0.6588 | -6.11 | -0.7036 | 75.70 | 89.83 | -56.34 | -4.46 | 3.62 | -8.25 | 0.5254 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
GNI Group Ltd | 26.01bn | 8.09bn | 149.87bn | 701.00 | 18.77 | 4.43 | 14.82 | 5.76 | 160.06 | 160.06 | 531.67 | 678.01 | 0.5402 | 1.78 | 7.33 | -- | 19.74 | 7.23 | 22.65 | 8.78 | 86.24 | 85.75 | 36.54 | 14.57 | 3.67 | 26.42 | 0.0931 | 0.00 | 49.32 | 38.97 | 1,981.71 | -- | 19.69 | -- |
Towa Pharmaceutical Co Ltd | 236.78bn | 11.74bn | 150.94bn | 4.30k | 12.29 | 0.969 | 4.72 | 0.6375 | 238.42 | 238.42 | 4,810.52 | 3,023.62 | 0.6134 | 1.62 | 3.73 | 55,090,510.00 | 3.04 | 4.73 | 3.80 | 6.39 | 34.66 | 41.27 | 4.96 | 8.06 | 1.48 | -- | 0.5686 | 19.97 | 26.11 | 17.46 | -86.17 | -19.46 | 14.66 | 13.63 |
KAKEN PHARMACEUTICAL CO., LTD. | 72.10bn | 2.97bn | 156.93bn | 1.13k | 43.72 | 0.9231 | 27.45 | 2.18 | 78.14 | 78.14 | 1,915.49 | 3,700.49 | 0.429 | 1.86 | 2.89 | 63,801,770.00 | 1.76 | 8.17 | 2.00 | 9.56 | 53.89 | 55.55 | 4.11 | 16.09 | 4.68 | -- | 0.0267 | 44.04 | -4.01 | -5.81 | -43.03 | -22.17 | 3.16 | 0.00 |
Sumitomo Pharma Co Ltd | 330.31bn | -173.72bn | 157.57bn | 6.25k | -- | 0.4579 | -- | 0.477 | -437.26 | -437.26 | 831.40 | 864.73 | 0.2717 | 1.36 | 2.71 | 52,849,120.00 | -14.95 | 1.15 | -22.20 | 1.67 | 59.93 | 72.18 | -55.04 | 2.54 | 0.3785 | -- | 0.5452 | 41.44 | -0.8019 | 3.54 | -232.08 | -- | 0.6204 | 3.13 |
Kissei Pharmaceutical Co Ltd | 73.72bn | 12.20bn | 174.32bn | 1.80k | 13.26 | 0.7995 | 10.54 | 2.36 | 266.51 | 266.51 | 1,612.29 | 4,421.72 | 0.3213 | 1.68 | 2.60 | 41,067,970.00 | 5.38 | 3.21 | 5.87 | 3.47 | 48.23 | 52.39 | 16.74 | 11.10 | 4.51 | -- | 0.007 | 36.56 | 3.23 | -1.83 | -18.52 | 3.08 | 3.74 | 10.76 |
Data as of Mar 29 2024. Currency figures normalised to Mochida Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 07 Mar 2024 | 815.13k | 2.18% |
Nomura Asset Management Co., Ltd.as of 29 Feb 2024 | 699.80k | 1.87% |
Asset Management One Co., Ltd.as of 30 Sep 2022 | 587.00k | 1.57% |
Nikko Asset Management Co., Ltd.as of 08 Mar 2024 | 328.00k | 0.88% |
BlackRock Fund Advisorsas of 07 Mar 2024 | 322.00k | 0.86% |
Daiwa Asset Management Co. Ltd.as of 29 Feb 2024 | 320.20k | 0.86% |
Norges Bank Investment Managementas of 31 Dec 2023 | 263.36k | 0.70% |
Dimensional Fund Advisors LPas of 07 Mar 2024 | 185.00k | 0.49% |
Mitsubishi UFJ Asset Management Co., Ltd.as of 31 Oct 2022 | 147.10k | 0.39% |
Charles Schwab Investment Management, Inc.as of 07 Mar 2024 | 104.58k | 0.28% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.